This study is looking at a new way to find breast cancer called Molecular Breast Imaging (MBI) in women with dense breasts. MBI uses a special injection and cameras to highlight cancer cells. Researchers want to see if MBI finds more cancers than standard 3D mammograms (DBT) and if it leads to more biopsies. They also want to check how well MBI-guided biopsies match pathology results. You could join if you are a woman aged 21 or older with dense breasts (BI-RADS C or D). The study aims to enroll 250 participants. The current status of the study is unclear.

Study design

This is a pilot single-group crossover study comparing MBI to DBT. It plans to enroll 250 women.

What's involved

You will receive both a screening DBT and a supplemental screening MBI. If a biopsy is needed, you will be randomly assigned to either a DBT-guided or MBI-guided biopsy.

Compensation

Not stated in the trial record.

Follow-up

Cancer detection rate is measured at less than one day after screening.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.